CARBIDOPA; LEVODOPA |
208895 |
001 |
ANDA |
CARBIDOPA;LEVODOPA |
CAPSULE, EXTENDED RELEASE;ORAL |
23.75MG;95MG |
No
|
No
|
2023/03/31
(TA)
|
--
|
SANDOZ INC |
None (Tentative Approval) |
CARBIDOPA; LEVODOPA |
208895 |
002 |
ANDA |
CARBIDOPA;LEVODOPA |
CAPSULE, EXTENDED RELEASE;ORAL |
36.25MG;145MG |
No
|
No
|
2023/03/31
(TA)
|
--
|
SANDOZ INC |
None (Tentative Approval) |
CARBIDOPA; LEVODOPA |
208895 |
003 |
ANDA |
CARBIDOPA;LEVODOPA |
CAPSULE, EXTENDED RELEASE;ORAL |
48.75MG;195MG |
No
|
No
|
2023/03/31
(TA)
|
--
|
SANDOZ INC |
None (Tentative Approval) |
CARBIDOPA; LEVODOPA |
208895 |
004 |
ANDA |
CARBIDOPA;LEVODOPA |
CAPSULE, EXTENDED RELEASE;ORAL |
61.25MG;245MG |
No
|
No
|
2023/03/31
(TA)
|
--
|
SANDOZ INC |
None (Tentative Approval) |